Go Pro
→ They didn't warn anyone in 1971. This time someone is warning you. (From Reagan Gold Group) (Ad)tc pixel Free GERN Stock Alerts

Geron (GERN) Financials

Geron logo
$1.32 -0.05 (-3.28%)
As of 10:20 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for Geron

Annual Income Statements for Geron

This table shows Geron's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 0.05 -30 -28 -27 -69 -76 -116 -142 -184 -175 -84
Consolidated Net Income / (Loss)		 0.05 -30 -28 -27 -69 -76 -116 -142 -184 -175 -84
Net Income / (Loss) Continuing Operations		 0.05 -30 -28 -27 -69 -76 -116 -142 -184 -175 -84
Total Pre-Tax Income 		0.05 -30 -28 -27 -69 -76 -116 -142 -184 -175 -84
Total Operating Income		 -0.56 -31 -29 -31 -73 -77 -114 -139 -194 -174 -69
Total Gross Profit		 36 6.16 1.07 1.07 0.46 0.25 1.39 0.00 0.00 76 179
Total Revenue		 36 6.16 1.07 1.07 0.46 0.25 1.39 0.00 0.00 77 184
Operating Revenue		 36 6.16 1.07 1.07 0.46 0.25 1.39 0.00 0.00 77 184
Total Cost of Revenue		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.26 4.75
Operating Cost of Revenue		 - - - - - - - 0.00 0.00 1.26 4.75
Total Operating Expenses		 37 37 30 32 73 77 115 139 194 249 248
Selling, General & Admin Expense		 18 19 19 19 21 26 30 44 69 146 159
Research & Development Expense		 18 18 11 13 52 51 86 96 125 104 71
Restructuring Charge		 1.31 - - - - - - - 0.00 0.00 17
Total Other Income / (Expense), net		 0.61 1.11 1.34 4.06 3.96 1.30 -2.11 -3.35 9.82 -0.84 -15
Interest Expense		 - - - 0.00 0.00 0.76 3.74 6.88 8.31 20 33
Interest & Investment Income		 0.68 1.19 1.42 3.25 4.22 1.83 0.53 2.53 18 20 18
Other Income / (Expense), net		 -0.07 -0.08 -0.08 0.81 -0.26 0.23 1.10 1.00 -0.02 -0.24 -0.38
Basic Earnings per Share		 $0.00 ($0.19) ($0.18) ($0.15) ($0.36) ($0.28) ($0.35) ($0.37) ($0.32) ($0.27) ($0.13)
Weighted Average Basic Shares Outstanding		 158.04M 159.05M 159.22M 176.50M 190.16M 271.46M 327.63M 380.78M 570.65M 646.03M 666.66M
Diluted Earnings per Share		 $0.00 ($0.19) ($0.18) ($0.15) ($0.36) ($0.28) ($0.35) ($0.37) ($0.32) ($0.27) ($0.13)
Weighted Average Diluted Shares Outstanding		 162.66M 159.05M 159.22M 176.50M 190.16M 271.46M 327.63M 380.78M 570.65M 646.03M 666.66M
Weighted Average Basic & Diluted Shares Outstanding		 158.92M 159.05M 159.22M 176.50M 190.16M 271.46M 327.63M 508.72M 546.06M 636.90M 640.54M

Quarterly Income Statements for Geron

This table shows Geron's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 -52 -55 -67 -26 -25 -20 -16 -18 -29 -3.64 -17
Consolidated Net Income / (Loss)		 -52 -55 -67 -26 -25 -20 -16 -18 -29 -3.64 -17
Net Income / (Loss) Continuing Operations		 -52 -55 -67 -26 -25 -20 -16 -18 -29 -3.64 -17
Total Pre-Tax Income 		-52 -55 -67 -26 -25 -20 -16 -18 -29 -3.64 -17
Total Operating Income		 -54 -56 -69 -28 -20 -17 -12 -14 -26 0.16 -12
Total Gross Profit		 -0.19 0.30 0.87 28 47 38 48 46 47 50 48
Total Revenue		 -0.19 0.30 0.88 28 48 40 49 47 48 52 57
Operating Revenue		 - 0.30 0.88 28 - 40 49 47 48 52 57
Total Cost of Revenue		 - 0.00 0.02 0.46 0.78 1.21 1.19 1.04 1.31 1.69 9.24
Operating Cost of Revenue		 - 0.00 0.02 0.46 - 1.21 1.19 1.04 1.31 1.69 9.24
Total Operating Expenses		 54 56 70 56 67 55 60 60 72 50 61
Selling, General & Admin Expense		 21 27 39 36 43 40 39 39 42 35 39
Research & Development Expense		 33 29 31 20 23 15 22 21 14 15 22
Restructuring Charge		 - - - - - 0.00 0.00 - - -0.39 -0.16
Total Other Income / (Expense), net		 2.32 0.74 1.95 1.77 -5.30 -3.13 -3.92 -4.54 -3.32 -3.80 -4.18
Interest Expense		 2.32 3.43 3.32 3.05 10 8.20 8.52 8.64 7.30 7.15 7.15
Interest & Investment Income		 4.60 4.24 5.33 4.88 5.16 5.15 4.66 4.26 4.05 3.42 2.97
Other Income / (Expense), net		 0.04 -0.06 -0.06 -0.06 -0.05 -0.08 -0.06 -0.16 -0.07 -0.07 -0.01
Basic Earnings per Share		 ($0.08) ($0.09) ($0.10) ($0.04) ($0.04) ($0.03) ($0.02) ($0.03) ($0.05) ($0.01) ($0.02)
Weighted Average Basic Shares Outstanding		 570.65M 603.49M 653.90M 662.16M 646.03M 665.91M 666.17K 667.10M 666.66M 669.38K 670.70K
Diluted Earnings per Share		 ($0.08) ($0.09) ($0.10) ($0.04) ($0.04) ($0.03) ($0.02) ($0.03) ($0.05) ($0.01) ($0.02)
Weighted Average Diluted Shares Outstanding		 570.65M 603.49M 653.90M 662.16M 646.03M 665.91M 666.17K 667.10M 666.66M 669.38K 670.70K
Weighted Average Basic & Diluted Shares Outstanding		 546.06M 593.13M 602.80M 604.50M 636.90M 636.92M 638.02M 638.36M 640.54M 641.52M 642.47M

Annual Cash Flow Statements for Geron

This table details how cash moves in and out of Geron's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -22 -8.44 3.53 -5.76 3.07 -3.63 25 22 14 9.74 -1.44
Net Cash From Operating Activities		 -24 -18 -21 -21 -44 -67 -96 -127 -168 -219 -111
Net Cash From Continuing Operating Activities		 -24 -18 -21 -21 -44 -67 -96 -127 -168 -219 -111
Net Income / (Loss) Continuing Operations		 0.05 -30 -28 -27 -69 -76 -116 -142 -184 -175 -84
Consolidated Net Income / (Loss)		 0.05 -30 -28 -27 -69 -76 -116 -142 -184 -175 -84
Depreciation Expense		 0.06 0.08 0.08 0.06 0.06 0.16 0.22 0.29 0.44 0.55 0.47
Amortization Expense		 2.10 0.55 0.27 -0.98 -0.82 1.77 2.89 0.94 -9.47 -12 -5.12
Non-Cash Adjustments To Reconcile Net Income		 11 10 6.76 7.55 18 6.73 5.90 6.88 21 35 32
Changes in Operating Assets and Liabilities, net		 -37 0.32 0.26 -0.63 7.10 0.30 12 6.41 4.57 -67 -55
Net Cash From Investing Activities		 0.07 8.76 23 -78 27 -105 72 62 -180 -106 107
Net Cash From Continuing Investing Activities		 0.07 8.76 23 -78 27 -105 72 62 -180 -106 107
Purchase of Property, Plant & Equipment		 -0.09 -0.06 - -0.02 -0.41 -0.40 -0.21 -0.43 -0.83 -0.68 -0.05
Purchase of Investments		 -206 -129 -100 -188 -153 -313 -177 -258 -476 -477 -304
Sale and/or Maturity of Investments		 207 138 123 111 181 208 248 321 296 372 412
Net Cash From Financing Activities		 2.58 1.17 1.11 93 19 168 49 87 362 334 2.27
Net Cash From Continuing Financing Activities		 2.58 1.17 1.11 93 19 168 49 87 362 334 2.27
Repayment of Debt		 - - - - - - - 0.00 0.00 -87 0.00
Issuance of Debt		 - - - 0.00 0.00 24 25 0.00 30 121 0.00
Issuance of Common Equity		 2.58 1.17 1.11 93 19 144 21 72 226 173 2.27
Other Financing Activities, net		 - - - 0.00 0.00 0.02 2.48 15 106 126 0.00
Effect of Exchange Rate Changes		 - - - - - - 0.00 0.02 -0.03 -0.01 0.09

Quarterly Cash Flow Statements for Geron

This table details how cash moves in and out of Geron's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 40 120 -73 -56 19 4.73 -6.01 0.39 -0.55 -8.66 -6.25
Net Cash From Operating Activities		 -41 -62 -53 -59 -44 -48 -27 -14 -22 -63 -16
Net Cash From Continuing Operating Activities		 -41 -62 -53 -59 -44 -48 -27 -14 -22 -63 -16
Net Income / (Loss) Continuing Operations		 -52 -55 -67 -26 -25 -20 -16 -18 -29 -3.64 -17
Consolidated Net Income / (Loss)		 -52 -55 -67 -26 -25 -20 -16 -18 -29 -3.64 -17
Depreciation Expense		 0.11 0.11 0.26 0.03 0.14 0.13 0.13 0.13 0.09 0.13 0.14
Amortization Expense		 -2.34 -1.40 -1.67 -1.82 -7.23 -1.78 -1.30 -1.07 -0.97 -0.59 -0.21
Non-Cash Adjustments To Reconcile Net Income		 6.08 4.97 13 6.91 10 8.67 8.71 8.11 6.61 5.10 10
Changes in Operating Assets and Liabilities, net		 7.18 -11 2.67 -38 -22 -35 -19 -2.32 1.08 -64 -9.38
Net Cash From Investing Activities		 48 34 -36 -0.55 -104 52 20 13 21 52 8.30
Net Cash From Continuing Investing Activities		 48 34 -36 -0.55 -104 52 20 13 21 52 8.30
Purchase of Property, Plant & Equipment		 -0.06 -0.62 -0.21 - 0.14 0.03 -0.17 0.09 - -0.25 -0.22
Purchase of Investments		 -16 -66 -161 -66 -185 -46 -77 -77 -104 -35 -89
Sale and/or Maturity of Investments		 64 100 125 65 81 99 97 90 125 87 97
Net Cash From Financing Activities		 33 148 17 3.58 166 0.26 1.09 0.54 0.38 2.43 1.38
Net Cash From Continuing Financing Activities		 33 148 17 3.58 166 0.26 1.09 0.54 0.38 2.43 1.38
Issuance of Common Equity		 3.58 148 16 3.57 5.62 0.26 1.09 0.54 0.38 0.91 1.38
Effect of Exchange Rate Changes		 -0.02 -0.01 -0.02 0.05 - 0.02 0.00 0.08 -0.01 -0.04 -0.10

Annual Balance Sheets for Geron

This table presents Geron's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 149 130 110 185 166 271 226 191 394 594 571
Total Current Assets		 116 116 96 166 142 200 187 180 341 491 520
Cash & Equivalents		 21 13 16 11 14 9.93 35 57 70 79 78
Restricted Cash		 0.27 0.27 0.27 0.27 0.27 0.36 0.36 0.36 1.12 1.86 1.88
Short-Term Investments		 93 102 78 153 126 186 149 116 264 328 280
Note & Lease Receivable		 1.21 0.48 0.44 1.17 0.80 0.72 1.76 3.14 1.66 2.85 2.24
Accounts Receivable		 - - - - - - - - 0.00 36 37
Inventories, net		 - - - - - - - - 0.00 39 117
Prepaid Expenses		 0.65 0.52 0.58 1.33 1.21 2.50 1.36 3.99 4.88 5.05 4.61
Plant, Property, & Equipment, net		 0.21 0.18 0.10 0.06 0.41 0.66 0.65 0.79 1.18 1.31 0.88
Total Noncurrent Assets		 33 14 14 19 24 70 38 9.54 52 101 49
Long-Term Investments		 33 14 14 19 20 63 29 0.00 43 95 41
Other Noncurrent Operating Assets		 - - - 0.59 3.85 6.83 9.53 9.54 8.25 6.96 8.10
Total Liabilities & Shareholders' Equity		 149 130 110 185 166 271 226 191 394 594 571
Total Liabilities		 6.63 7.87 6.52 7.55 30 60 100 111 146 313 345
Total Current Liabilities		 6.63 7.87 6.52 7.55 28 31 46 77 108 88 112
Accounts Payable		 0.16 0.23 0.50 0.98 1.18 6.92 6.69 10 6.16 8.60 11
Accrued Expenses		 3.45 4.80 0.93 1.32 7.53 15 30 33 40 36 51
Current Employee Benefit Liabilities		 3.03 2.84 3.39 2.64 4.83 8.22 8.10 12 14 23 30
Other Current Liabilities		 - - 1.70 2.61 15 0.88 0.90 0.93 0.95 21 18
Total Noncurrent Liabilities		 0.00 0.00 0.00 0.00 2.20 29 54 34 38 225 233
Long-Term Debt		 - - - - 0.00 24 50 30 35 118 120
Other Noncurrent Operating Liabilities		 - - - - 2.20 4.80 4.27 3.67 3.01 107 114
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 142 122 104 178 135 211 126 80 248 280 226
Total Preferred & Common Equity		 142 122 104 178 135 211 126 80 248 280 226
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 142 122 104 178 135 211 126 80 248 280 226
Common Stock		 1,071 1,080 1,090 1,189 1,215 1,366 1,398 1,494 1,846 2,052 2,081
Retained Earnings		 -928 -958 -986 -1,011 -1,080 -1,156 -1,272 -1,414 -1,598 -1,772 -1,856
Accumulated Other Comprehensive Income / (Loss)		 -0.21 -0.05 -0.21 -0.18 0.13 0.08 -0.17 -0.22 0.19 0.26 0.27

Quarterly Balance Sheets for Geron

This table presents Geron's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets		 425 415 413 482 449 445 562 555 567 534 519
Total Current Assets		 387 377 335 452 373 398 496 506 522 499 486
Cash & Equivalents		 113 57 31 190 117 60 84 78 78 69 63
Restricted Cash		 0.37 0.54 0.54 1.12 1.12 1.85 1.87 1.87 1.88 1.88 1.89
Short-Term Investments		 268 314 283 253 246 279 313 310 302 244 238
Note & Lease Receivable		 1.60 1.19 15 1.63 2.25 2.08 2.82 2.76 2.30 2.21 1.86
Accounts Receivable		 - - - - 0.87 28 31 37 35 42 52
Inventories, net		 - - - - 0.77 20 56 69 95 133 124
Prepaid Expenses		 4.32 4.18 6.27 5.71 5.55 6.06 6.82 7.26 6.86 6.86 6.50
Plant, Property, & Equipment, net		 1.07 1.15 1.23 1.68 1.63 1.60 1.15 1.19 0.97 1.00 1.09
Total Noncurrent Assets		 37 37 77 29 74 45 66 48 44 35 32
Long-Term Investments		 28 28 68 21 67 37 59 43 39 27 24
Other Noncurrent Operating Assets		 8.69 8.59 8.88 8.10 7.96 7.99 6.74 5.67 5.00 7.90 7.46
Total Liabilities & Shareholders' Equity		 425 415 413 482 449 445 562 555 567 534 519
Total Liabilities		 99 117 122 137 143 153 294 296 319 305 300
Total Current Liabilities		 44 73 89 123 104 138 63 64 88 74 70
Accounts Payable		 3.38 7.67 14 9.99 5.62 14 8.03 8.23 11 13 8.81
Accrued Expenses		 35 45 42 34 39 36 29 26 40 31 31
Current Employee Benefit Liabilities		 4.91 8.23 11 6.79 11 15 9.60 11 16 9.49 9.11
Other Current Liabilities		 0.93 0.79 0.94 0.96 0.96 0.97 17 18 20 20 22
Total Noncurrent Liabilities		 55 44 33 14 39 15 231 231 231 231 230
Long-Term Debt		 51 41 30 11 37 12 119 119 119 120 120
Other Noncurrent Operating Liabilities		 3.51 3.50 3.18 2.83 2.65 2.46 112 112 112 112 110
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 326 298 291 345 307 292 268 260 249 229 219
Total Preferred & Common Equity		 326 298 291 345 307 292 268 260 249 229 219
Preferred Stock		 - - - - - - - - - 0.00 0.00
Total Common Equity		 326 298 291 345 307 292 268 260 249 229 219
Common Stock		 1,778 1,800 1,837 1,998 2,028 2,038 2,060 2,068 2,075 2,089 2,095
Retained Earnings		 -1,452 -1,501 -1,546 -1,653 -1,721 -1,747 -1,792 -1,809 -1,827 -1,859 -1,876
Accumulated Other Comprehensive Income / (Loss)		 -0.16 -0.95 -0.95 -0.27 -0.54 1.02 0.30 0.12 0.41 -0.19 -0.34

Annual Metrics And Ratios for Geron

This table displays calculated financial ratios and metrics derived from Geron's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 - - - - - - - - - - 638,355,275.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 638,355,275.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - -0.13
Growth Metrics		 - - - - - - - - - - -
Profitability Metrics		 - - - - - - - - - - -
Net Operating Profit after Tax (NOPAT)		 -0.56 -21 -20 -22 -51 -54 -80 -97 -136 -122 -48
Return On Investment Capital (ROIC_SIMPLE)		 -0.39% -17.53% -19.73% -12.24% -37.55% -22.91% -45.28% -73.95% -41.15% -30.49% -13.90%
Earnings before Interest and Taxes (EBIT)		 -0.63 -31 -29 -30 -73 -77 -113 -138 -194 -174 -69
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 1.52 -30 -29 -31 -74 -75 -110 -136 -203 -186 -74
Valuation Ratios		 - - - - - - - - - - -
Leverage & Solvency		 - - - - - - - - - - -
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -36 -19 -22 -23 -31 -53 -68 -92 -129 -66 -96
Efficiency Ratios		 - - - - - - - - - - -
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -4.57 -6.69 -5.40 -4.41 -24 -25 -36 -42 -48 -104 -56
Increase / (Decrease) in Invested Capital		 35 -2.11 1.29 0.99 -20 -0.95 -11 -5.46 -6.26 -56 48
Book Value per Share		 $0.90 $0.77 $0.65 $0.95 $0.68 $0.68 $0.39 $0.21 $0.46 $0.46 $0.35
Tangible Book Value per Share		 $0.90 $0.77 $0.65 $0.95 $0.68 $0.68 $0.39 $0.21 $0.46 $0.46 $0.35
Total Capital		 142 122 104 178 135 235 176 131 330 399 345
Total Debt		 0.00 0.00 0.00 0.00 0.00 24 50 51 82 118 120
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 24 50 30 35 118 120
Net Debt		 -147 -129 -109 -182 -159 -236 -163 -122 -296 -384 -282
Capital Expenditures (CapEx)		 0.09 0.04 0.00 0.02 0.41 0.06 -1.39 0.43 0.83 0.68 0.05
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -4.78 -6.87 -5.50 -5.05 -26 -28 -42 -49 -55 -5.73 49
Debt-free Net Working Capital (DFNWC)		 109 108 89 159 113 169 142 124 280 403 409
Net Working Capital (NWC)		 109 108 89 159 113 169 142 104 233 403 409
Net Nonoperating Expense (NNE)		 -0.61 8.08 7.44 5.27 18 22 36 45 48 53 35
Net Nonoperating Obligations (NNO)		 -147 -129 -109 -182 -159 -236 -163 -122 -296 -384 -282
Total Depreciation and Amortization (D&A)		 2.15 0.63 0.35 -0.92 -0.76 1.93 3.10 1.23 -9.03 -12 -4.65
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 ($0.19) ($0.18) ($0.15) ($0.36) ($0.28) ($0.35) ($0.37) ($0.32) ($0.27) ($0.13)
Adjusted Weighted Average Basic Shares Outstanding		 158.04M 159.05M 159.22M 186.39M 200.34M 318.53M 323.73M 380.78M 570.65M 646.03M 666.66M
Adjusted Diluted Earnings per Share		 $0.00 ($0.19) ($0.18) ($0.15) ($0.36) ($0.28) ($0.35) ($0.37) ($0.32) ($0.27) ($0.13)
Adjusted Weighted Average Diluted Shares Outstanding		 162.66M 159.05M 159.22M 186.39M 200.34M 318.53M 323.73M 380.78M 570.65M 646.03M 666.66M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 ($0.15) ($0.36) ($0.28) ($0.35) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 158.92M 159.16M 160.65M 176.50M 190.16M 271.46M 327.63M 508.72M 546.06M 636.90M 640.54M
Normalized Net Operating Profit after Tax (NOPAT)		 0.52 -21 -20 -22 -51 -54 -80 -97 -136 -122 -36
Debt Service Ratios		 - - - - - - - - - - -
Payout Ratios		 - - - - - - - - - - -

Quarterly Metrics And Ratios for Geron

This table displays calculated financial ratios and metrics derived from Geron's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 - - - - - - - - 638,355,275.00 640,544,661.00 641,520,974.00
DEI Adjusted Shares Outstanding		 - - - - - - - - 638,355,275.00 640,544,661.00 641,520,974.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - -0.05 -0.01 -0.03
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 54.05% 0.00% 2,941.38% 17,138.41% 24,888.08% 12,927.30% 5,459.64% 67.05% - 30.89% 17.22%
EBITDA Growth		 -33.30% -39.24% -29.49% 40.53% 51.86% 67.93% 80.68% 50.13% - 97.98% 8.03%
EBIT Growth		 -29.58% -40.30% -33.55% 40.72% 62.95% 70.13% 81.97% 50.32% - 100.50% 0.08%
NOPAT Growth		 -29.41% -40.01% -33.46% 40.74% 63.07% 70.24% 82.04% 50.78% - 100.95% -0.34%
Net Income Growth		 -21.90% -45.30% -36.88% 40.97% 51.22% 64.19% 75.70% 30.32% - 81.64% -1.86%
EPS Growth		 27.27% -28.57% -11.11% 50.00% 50.00% 66.67% 80.00% 25.00% - 66.67% 0.00%
Operating Cash Flow Growth		 -16.36% -34.27% -80.66% -15.94% -7.35% 22.93% 48.74% 76.97% - -31.11% 42.27%
Free Cash Flow Firm Growth		 -32.79% -26.60% -335.14% -86.58% 232.00% 163.90% 108.77% 172.75% - -464.09% -1,558.17%
Invested Capital Growth		 -14.93% -17.59% 19.74% 92.84% -115.99% -89.01% -34.40% -1,797.84% - 111.29% 121.98%
Revenue Q/Q Growth		 -217.68% 100.00% 0.00% 3,105.33% 69.22% -17.22% 23.82% -3.69% - 7.96% 10.89%
EBITDA Q/Q Growth		 -11.71% -1.79% -23.17% 57.54% 9.57% 32.19% 25.79% -9.57% - 98.59% -3,273.46%
EBIT Q/Q Growth		 -13.72% -3.59% -23.49% 59.25% 28.93% 16.47% 25.45% -12.25% - 100.33% -14,986.90%
NOPAT Q/Q Growth		 -14.02% -3.40% -23.51% 59.31% 28.94% 16.69% 25.44% -11.51% - 100.62% -8,008.86%
Net Income Q/Q Growth		 -16.00% -6.57% -21.65% 60.75% 4.14% 21.76% 17.44% -12.54% - 87.38% -357.99%
EPS Q/Q Growth		 0.00% -12.50% -11.11% 60.00% 0.00% 25.00% 33.33% -50.00% - 80.00% -100.00%
Operating Cash Flow Q/Q Growth		 19.48% -52.07% 14.10% -10.22% 25.44% -9.18% 42.86% 50.48% - -185.07% 74.84%
Free Cash Flow Firm Q/Q Growth		 -5.17% -6.21% -73.32% 3.63% 174.41% -48.58% -76.22% 699.50% - -18.19% 4.75%
Invested Capital Q/Q Growth		 -22.47% 22.57% -7.75% 92.99% -3,594.54% 32.24% 23.38% 1.06% - 114.32% 49.13%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 0.00% 0.00% 98.07% 98.39% 98.36% 96.95% 97.57% 97.79% - 96.74% 83.92%
EBITDA Margin		 0.00% 0.00% -8,027.55% -106.34% -56.83% -46.55% -27.90% -31.74% - -0.72% -21.89%
Operating Margin		 0.00% 0.00% -7,860.88% -99.80% -41.91% -42.18% -25.40% -29.40% - 0.30% -21.74%
EBIT Margin		 0.00% 0.00% -7,868.03% -100.02% -42.01% -42.39% -25.52% -29.75% - 0.16% -21.76%
Profit (Net Income) Margin		 0.00% 0.00% -7,639.80% -93.55% -52.99% -50.08% -33.39% -39.02% - -7.03% -29.02%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% - 100.00% 100.00%
Interest Burden Percent		 95.81% 98.57% 97.10% 93.53% 126.14% 118.16% 130.84% 131.18% - -4,335.71% 133.39%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Return on Equity (ROE)		 -112.29% -60.04% -72.56% -69.03% -66.09% -45.35% -31.09% -29.57% - -27.07% -28.28%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - -1,439.74% -859.78%
Operating Return on Assets (OROA)		 0.00% 0.00% -15.52% -6.75% -6.55% -9.44% -8.36% -10.78% - 0.06% -8.29%
Return on Assets (ROA)		 0.00% 0.00% -15.07% -6.32% -8.26% -11.15% -10.93% -14.14% - -2.51% -11.05%
Return on Common Equity (ROCE)		 -112.29% -60.04% -72.56% -69.03% -66.09% -45.35% -31.09% -29.57% - -27.07% -28.28%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -58.40% -71.59% -68.83% 0.00% -51.83% 0.00% 0.00% - 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -38 -39 -49 -20 -14 -12 -8.72 -9.72 -18 0.11 -8.75
NOPAT Margin		 0.00% 0.00% -5,502.62% -69.86% -29.34% -29.53% -17.78% -20.58% - 0.21% -15.22%
Net Nonoperating Expense Percent (NNEP)		 -6.68% -4.35% -5.42% -2.14% -3.33% -2.26% -2.32% -2.92% - -1.34% -3.05%
Return On Investment Capital (ROIC_SIMPLE)		 -11.52% -9.19% -12.44% -5.25% -3.52% -3.02% -2.30% -2.64% -5.18% 0.03% -2.58%
Cost of Revenue to Revenue		 0.00% 0.00% 1.93% 1.61% 1.64% 3.05% 2.43% 2.21% - 3.26% 16.08%
SG&A Expenses to Revenue		 0.00% 0.00% 4,469.27% 126.90% 90.66% 101.06% 78.64% 82.58% - 68.34% 67.61%
R&D to Revenue		 0.00% 0.00% 3,489.68% 71.29% 48.98% 38.07% 44.33% 44.61% - 28.85% 38.33%
Operating Expenses to Revenue		 0.00% 0.00% 7,958.96% 198.19% 139.64% 139.13% 122.97% 127.20% - 96.43% 105.66%
Earnings before Interest and Taxes (EBIT)		 -54 -56 -69 -28 -20 -17 -13 -14 -26 0.08 -13
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -56 -57 -71 -30 -27 -18 -14 -15 -26 -0.37 -13
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 4.62 5.23 8.20 9.36 7.63 3.78 3.46 3.51 - 4.17 3.76
Price to Tangible Book Value (P/TBV)		 4.62 5.23 8.20 9.36 7.63 3.78 3.46 3.51 - 4.17 3.76
Price to Revenue (P/Rev)		 0.00 0.00 2,948.28 94.50 27.79 8.71 5.46 4.77 - 4.87 4.01
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 92.00 51.69
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 2,541.57 84.31 22.80 5.79 3.55 3.12 - 3.74 3.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 87.79 - 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.33 0.24 0.27 0.29 0.42 0.44 0.46 0.48 - 0.52 0.55
Long-Term Debt to Equity		 0.14 0.03 0.12 0.04 0.42 0.44 0.46 0.48 - 0.52 0.55
Financial Leverage		 -1.28 -1.10 -1.15 -1.07 -1.29 -1.18 -1.17 -1.10 - -1.13 -1.09
Leverage Ratio		 1.78 1.35 1.43 1.47 1.87 1.70 1.77 1.87 - 2.20 2.25
Compound Leverage Factor		 1.71 1.33 1.39 1.38 2.36 2.01 2.32 2.45 - -95.60 3.00
Debt to Total Capital		 24.84% 19.35% 21.39% 22.29% 29.71% 30.68% 31.44% 32.41% - 34.34% 35.46%
Short-Term Debt to Total Capital		 14.21% 16.73% 12.03% 19.03% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Long-Term Debt to Total Capital		 10.63% 2.62% 9.36% 3.26% 29.71% 30.68% 31.44% 32.41% - 34.34% 35.46%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Common Equity to Total Capital		 75.16% 80.65% 78.61% 77.71% 70.29% 69.32% 68.56% 67.59% - 65.66% 64.54%
Debt to EBITDA		 -0.40 -0.38 -0.35 -0.39 -0.64 -0.81 -1.33 -1.61 - -2.16 -2.21
Net Debt to EBITDA		 1.46 1.74 1.47 1.37 2.07 2.31 3.51 4.07 - 3.98 3.80
Long-Term Debt to EBITDA		 -0.17 -0.05 -0.16 -0.06 -0.64 -0.81 -1.33 -1.61 - -2.16 -2.21
Debt to NOPAT		 -0.60 -0.56 -0.52 -0.58 -0.97 -1.26 -2.20 -2.70 - -3.31 -3.32
Net Debt to NOPAT		 2.18 2.60 2.18 2.03 3.16 3.60 5.79 6.84 - 6.11 5.71
Long-Term Debt to NOPAT		 -0.26 -0.08 -0.23 -0.08 -0.97 -1.26 -2.20 -2.70 - -3.31 -3.32
Altman Z-Score		 -0.72 3.51 5.43 5.82 0.75 -1.36 -1.56 -1.70 - -1.67 -2.14
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 3.16 3.67 3.61 2.89 5.56 7.87 7.87 5.96 - 6.78 6.92
Quick Ratio		 3.10 3.61 3.53 2.68 5.04 6.84 6.65 4.77 - 4.85 5.04
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -32 -34 -58 -56 42 22 5.12 41 -66 -78 -75
Operating Cash Flow to CapEx		 -63,965.63% -10,122.44% -25,960.19% 0.00% 0.00% 0.00% -16,126.47% 0.00% - -24,962.70% -7,097.31%
Free Cash Flow to Firm to Interest Expense		 -13.67 -9.82 -17.60 -18.48 4.02 2.63 0.60 4.74 - -10.97 -10.45
Operating Cash Flow to Interest Expense		 -17.64 -18.13 -16.11 -19.35 -4.22 -5.85 -3.22 -1.57 - -8.80 -2.21
Operating Cash Flow Less CapEx to Interest Expense		 -17.67 -18.31 -16.17 -19.35 -4.21 -5.85 -3.24 -1.56 - -8.84 -2.25
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.07 0.16 0.22 0.33 0.36 - 0.36 0.38
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 8.77 5.79 - 5.37 4.64
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.10 0.07 - 0.06 0.14
Fixed Asset Turnover		 0.00 0.00 0.62 20.50 61.92 82.24 116.84 142.84 - 182.69 179.60
Accounts Payable Turnover		 0.00 0.00 0.00 0.03 0.17 0.27 0.53 0.34 - 0.50 1.56
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00 0.00 41.60 63.06 - 67.98 78.73
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 3,509.37 5,001.46 - 6,611.62 2,648.37
Days Payable Outstanding (DPO)		 0.00 0.00 142,704.26 10,578.83 2,144.08 1,336.06 695.16 1,073.95 - 724.00 234.03
Cash Conversion Cycle (CCC)		 0.00 0.00 -142,704.26 -10,578.83 -2,144.08 -1,336.06 2,855.81 3,990.57 - 5,955.60 2,493.07
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -48 -37 -40 -2.82 -104 -71 -54 -54 -56 7.97 12
Invested Capital Turnover		 0.00 0.00 -0.02 -1.37 -1.01 -2.16 -3.49 -6.51 - -6.27 -9.70
Increase / (Decrease) in Invested Capital		 -6.26 -5.59 9.89 37 -56 -33 -14 -51 48 79 66
Enterprise Value (EV)		 850 1,420 2,168 2,442 1,755 674 584 572 - 733 614
Market Capitalization		 1,146 1,802 2,515 2,737 2,140 1,013 898 874 - 954 821
Book Value per Share		 $0.46 $0.63 $0.52 $0.48 $0.46 $0.42 $0.41 $0.39 $0.35 $0.36 $0.34
Tangible Book Value per Share		 $0.46 $0.63 $0.52 $0.48 $0.46 $0.42 $0.41 $0.39 $0.35 $0.36 $0.34
Total Capital		 330 428 390 376 399 387 379 368 345 349 339
Total Debt		 82 83 83 84 118 119 119 119 120 120 120
Total Long-Term Debt		 35 11 37 12 118 119 119 119 120 120 120
Net Debt		 -296 -382 -347 -295 -384 -339 -314 -302 -282 -221 -207
Capital Expenditures (CapEx)		 0.06 0.62 0.21 0.00 -0.14 -0.03 0.17 -0.09 0.00 0.25 0.22
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -55 -44 -47 -9.94 -5.73 34 51 52 49 111 113
Debt-free Net Working Capital (DFNWC)		 280 400 317 332 403 433 441 435 409 425 416
Net Working Capital (NWC)		 233 328 270 260 403 433 441 435 409 425 416
Net Nonoperating Expense (NNE)		 14 16 19 6.70 11 8.14 7.66 8.71 11 3.75 7.93
Net Nonoperating Obligations (NNO)		 -296 -382 -347 -295 -384 -339 -314 -302 -282 -221 -207
Total Depreciation and Amortization (D&A)		 -2.23 -1.29 -1.41 -1.79 -7.09 -1.65 -1.17 -0.94 -0.89 -0.46 -0.08
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% -5,530.13% -34.33% -7.44% 29.23% 31.29% 28.47% - 56.43% 55.37%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 37,126.03% 1,145.32% 523.02% 372.11% 268.36% 236.98% - 216.69% 203.37%
Net Working Capital to Revenue		 0.00% 0.00% 31,625.79% 898.22% 523.02% 372.11% 268.36% 236.98% - 216.69% 203.37%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.08) ($0.09) ($0.10) ($0.04) ($0.04) ($0.03) ($0.02) ($0.03) ($0.05) ($0.01) ($0.02)
Adjusted Weighted Average Basic Shares Outstanding		 570.65M 603.49M 653.90M 662.16M 646.03M 665.91M 666.17M 667.10M 666.66M 669.38K 670.70K
Adjusted Diluted Earnings per Share		 ($0.08) ($0.09) ($0.10) ($0.04) ($0.04) ($0.03) ($0.02) ($0.03) ($0.05) ($0.01) ($0.02)
Adjusted Weighted Average Diluted Shares Outstanding		 570.65M 603.49M 653.90M 662.16M 646.03M 665.91M 666.17M 667.10M 666.66M 669.38K 670.70K
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 546.06M 593.13M 602.80M 604.50M 636.90M 636.92M 638.02M 638.36M 640.54M 641.52M 642.47M
Normalized Net Operating Profit after Tax (NOPAT)		 -38 -39 -49 -20 -14 -12 -8.72 -9.72 -18 -0.17 -8.86
Normalized NOPAT Margin		 0.00% 0.00% -5,502.62% -69.86% -29.34% -29.53% -17.78% -20.58% - -0.32% -15.41%
Pre Tax Income Margin		 0.00% 0.00% -7,639.80% -93.55% -52.99% -50.08% -33.39% -39.02% - -7.03% -29.02%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -23.37 -16.37 -20.91 -9.28 -1.93 -2.05 -1.47 -1.63 - 0.01 -1.75
NOPAT to Interest Expense		 -16.37 -11.45 -14.62 -6.48 -1.35 -1.43 -1.02 -1.12 - 0.02 -1.22
EBIT Less CapEx to Interest Expense		 -23.40 -16.55 -20.97 -9.28 -1.92 -2.04 -1.49 -1.61 - -0.02 -1.78
NOPAT Less CapEx to Interest Expense		 -16.40 -11.63 -14.68 -6.48 -1.33 -1.42 -1.04 -1.11 - -0.02 -1.26
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Geron’s financial statements show a company transitioning from a development-stage business toward commercialization. Revenue has increased sharply, while operating losses and cash burn have generally improved from 2024 levels. However, Geron remains unprofitable, carries substantial long-term liabilities and continues to rely on its investment portfolio and equity issuance to support operations.

Revenue growth is the clearest positive trend. Quarterly revenue increased from essentially zero in 2022 and 2023 to $28.3 million in Q3 2024, $49.0 million in Q2 2025 and $57.5 million in Q2 2026. Q2 2026 revenue rose approximately 11% from Q1 2026 and 18% from Q2 2025. Gross profit was $48.2 million, representing an approximate 84% gross margin, although the company’s operating expenses still exceeded gross profit.

Profitability has improved significantly compared with earlier periods. The Q2 2026 operating loss was $12.5 million, down from $69.3 million in Q2 2024 and $40.0 million in Q3 2023. Geron briefly reported positive operating income of $158,000 in Q1 2026, but the company returned to an operating loss in the second quarter. Net losses have also narrowed over the longer term, although the Q2 2026 net loss of $16.7 million was considerably higher than the $3.6 million loss recorded in Q1 2026.

Geron’s balance sheet remains highly liquid in the near term. At June 30, 2026, the company held $62.6 million in cash, $1.9 million in restricted cash and $238.2 million in short-term investments. These assets substantially exceeded current liabilities of $70.3 million. Including long-term investments, Geron held approximately $326 million in cash and investment assets, providing financial flexibility as it continues expanding its commercial operations.

Cash flow trends are mixed but have improved from the most difficult periods. Operating cash outflow was $15.8 million in Q2 2026, compared with $53.5 million in Q2 2024 and $62.9 million in Q1 2026. The improvement from Q1 was partly offset by a $9.4 million use of operating working capital in Q2. Investment activity generated $8.3 million in cash during Q2 2026, while financing activity provided $1.4 million, including common-equity issuance.

  • Revenue momentum: Quarterly revenue has risen from negligible levels in 2022 to $57.5 million in Q2 2026, indicating meaningful commercial expansion.
  • Improving operating leverage: The operating loss has narrowed substantially, and Geron reached near break-even operating income in Q1 2026 despite continuing investment in research and development.
  • Strong liquidity position: Cash, restricted cash and short-term investments totaled approximately $303 million at the end of Q2 2026, far exceeding current liabilities.
  • Lower cash burn in the latest quarter: Operating cash outflow declined to $15.8 million in Q2 2026 from $62.9 million in Q1 and $53.5 million in Q2 2024.
  • High gross margins: Q2 2026 gross margin was approximately 84%, but the benefit was not enough to cover selling, general and administrative costs, research and development and other operating expenses.
  • Investment portfolio supports liquidity: Geron frequently purchases and sells or matures investments, creating positive investing cash flow in several quarters. This activity preserves flexibility but is not the same as cash generated by the company’s core operations.
  • Persistent net losses: Geron has reported net losses in every period provided, including a $16.7 million loss in Q2 2026. Retained earnings stood at a deficit of approximately $1.88 billion.
  • Volatile working-capital needs: Changes in operating assets and liabilities consumed $9.4 million of cash in Q2 2026 and $63.9 million in Q1 2026, making quarterly cash burn difficult to predict.
  • Material long-term obligations: Long-term debt was approximately $120.1 million at June 30, 2026, while other noncurrent operating liabilities totaled approximately $109.9 million. Interest expense was $7.1 million in Q2 2026.
  • Shareholder dilution: Weighted-average basic shares increased from approximately 404 million in Q2 2022 to approximately 671 million in Q2 2026. Continued equity issuance could provide funding but may reduce each existing shareholder’s ownership percentage.

Overall, Geron’s financial trajectory is improving as revenue scales and operating losses decline, but the company has not yet demonstrated sustainable profitability or positive operating cash flow. Investors should focus on whether revenue growth continues, whether operating expenses stabilize and whether the recent reduction in cash burn persists without relying heavily on additional equity financing or investment-portfolio sales.

09/15/26 07:24 AM ETAI Generated. May Contain Errors.

Geron Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Geron's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Geron's net income appears to be on an upward trend, with a most recent value of -$83.50 million in 2025, falling from $46 thousand in 2015. The previous period was -$174.57 million in 2024. See where experts think Geron is headed by visiting Geron's forecast page.

Geron's total operating income in 2025 was -$68.59 million, based on the following breakdown:
  • Total Gross Profit: $179.14 million
  • Total Operating Expenses: $247.72 million

Over the last 10 years, Geron's total revenue changed from $36.37 million in 2015 to $183.88 million in 2025, a change of 405.6%.

Geron's total liabilities were at $344.67 million at the end of 2025, a 10.0% increase from 2024, and a 5,095.5% increase since 2015.

In the past 10 years, Geron's cash and equivalents has ranged from $9.93 million in 2020 to $79.02 million in 2024, and is currently $77.56 million as of their latest financial filing in 2025.

Over the last 10 years, Geron's book value per share changed from 0.90 in 2015 to 0.35 in 2025, a change of -60.6%.


Related Companies

Financial statements for NASDAQ:GERN last updated on 8/5/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
DOJ Admits It In Court—Your Cash Can Be Seized Without Warning
The Department of Justice recently argued in court that cash may not be legally your property - raising concer...
Priority Gold | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel